INDUCTION OF SPECIFIC IMMUNE TOLERANCE

诱导特异性免疫耐受

基本信息

  • 批准号:
    6607263
  • 负责人:
  • 金额:
    $ 29.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-15 至 2004-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from the Investigator's abstract): The immune system is the major biological defense system responsible for fighting disease. However, immune responses can also be detrimental. In the case of transplantation, although the immune system reacts appropriately, it nevertheless causes harm by destroying the transplanted organs. In autoimmune diseases, the immune system turns against self and attacks otherwise normal tissue. In both situations, it is important to suspend the destructive function of the immune system while maintaining normal immune responses. Presently, in the clinical situation, a general immune suppression is induced, and the patients' defenses against infectious challenges are impaired. Strategies are now being sought that successfully induce specific non-responsiveness (tolerance) without affecting normal immune functions. Important cells of the immune system are T cells. They control many immune responses and also act as effector cells. Their suppression is crucial for the induction of tolerance. Only cells that react with a given organ, e.g. a transplant or a target of an autoimmune disease, should be removed. As different types of cells express tissue-specific antigens, complete tolerance towards a given tissue is best induced by the tissue itself. This should be true for transplant rejections and also autoimmune diseases. It has long been held that the disease mechanisms underlying autoimmune diseases mimic those seen in transplant rejection. Therefore, it should be possible to adapt strategies that induce specific transplantation tolerance to the treatment of autoimmune diseases. The so-called veto-effect (conventional veto) has been shown to efficiently and specifically tolerize T cells. It functions by expression of the co-receptor CD8 on stimulator cells. Based on this original observation, the approach has been expanded toward the development of hybrid antibodies (hAb) that combine a targeting antibody moiety with the functional region of the CD4 or CD9 accessory molecules. The cells coated with these hAbs inhibited the activation of either CD4+ or CD8+ activation in a highly specific fashion. In the current application, it is proposed to examine the function and activity of the CD8 targeting hAb in animal models of organ transplantation.
描述:(改编自研究者摘要):免疫系统是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TERRY A POTTER其他文献

TERRY A POTTER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TERRY A POTTER', 18)}}的其他基金

Microscopy
显微镜检查
  • 批准号:
    8311795
  • 财政年份:
    2011
  • 资助金额:
    $ 29.02万
  • 项目类别:
Microscopy
显微镜检查
  • 批准号:
    7663284
  • 财政年份:
    2008
  • 资助金额:
    $ 29.02万
  • 项目类别:
Microscopy
显微镜检查
  • 批准号:
    7188253
  • 财政年份:
    2007
  • 资助金额:
    $ 29.02万
  • 项目类别:
CD8 Mediated Apoptosis During T Cell Development
T 细胞发育过程中 CD8 介导的细胞凋亡
  • 批准号:
    7154097
  • 财政年份:
    2004
  • 资助金额:
    $ 29.02万
  • 项目类别:
CD8 Mediated Apoptosis During T Cell Development
T 细胞发育过程中 CD8 介导的细胞凋亡
  • 批准号:
    6986117
  • 财政年份:
    2004
  • 资助金额:
    $ 29.02万
  • 项目类别:
CD8 Mediated Apoptosis During T Cell Development
T 细胞发育过程中 CD8 介导的细胞凋亡
  • 批准号:
    7320666
  • 财政年份:
    2004
  • 资助金额:
    $ 29.02万
  • 项目类别:
CD8 in the Immunological Synapse and in Thymocyte Death
CD8 在免疫突触和胸腺细胞死亡中的作用
  • 批准号:
    6780797
  • 财政年份:
    2004
  • 资助金额:
    $ 29.02万
  • 项目类别:
CD8 Mediated Apoptosis During T Cell Development
T 细胞发育过程中 CD8 介导的细胞凋亡
  • 批准号:
    6869103
  • 财政年份:
    2004
  • 资助金额:
    $ 29.02万
  • 项目类别:
LISTERIA PROTEINS EFFECTS ON CELL FUNCTION
李斯特菌蛋白质对细胞功能的影响
  • 批准号:
    2672561
  • 财政年份:
    1997
  • 资助金额:
    $ 29.02万
  • 项目类别:
LISTERIA PROTEINS EFFECTS ON CELL FUNCTION
李斯特菌蛋白质对细胞功能的影响
  • 批准号:
    2887056
  • 财政年份:
    1997
  • 资助金额:
    $ 29.02万
  • 项目类别:

相似海外基金

ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145834
  • 财政年份:
    1990
  • 资助金额:
    $ 29.02万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145832
  • 财政年份:
    1990
  • 资助金额:
    $ 29.02万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145835
  • 财政年份:
    1990
  • 资助金额:
    $ 29.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了